CosmosIn utero skin grafts use stem cells to treat neural tube defectsCosmosLab generated skin grafts might soon be used to repair life-threatening neural tube defects in infants. Myelomenigocele is a severe neural tube defect that results in spinal bo… Continue reading
Palestine Herald Press |
Stem–cell bill won’t end controversy over safety, efficacy
Palestine Herald Press AUSTIN — Wiping away tears, Rep. Drew Springer made a dramatic speech in the last days of the just-ended legislative session, urging lawmakers to approve “investigational” stem–cell treatments in Texas. The Muenster Republican told House members that … |
12newsnow.com |
Blood cancer treatment called ‘revolutionary’ after all study patients responded
12newsnow.com Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level … |
|
Stem–cell bill won’t end safety controversy
Weatherford Democrat Drew Springer made a dramatic speech in the last days of the just-ended legislative session, urging lawmakers to approve “investigational” stem–cell treatments in Texas. The Muenster Republican told House members that such therapies might offer folks … |
|
Stem–cell bill won’t end safety controversy
Weatherford Democrat Drew Springer made a dramatic speech in the last days of the just-ended legislative session, urging lawmakers to approve “investigational” stem–cell treatments in Texas. The Muenster Republican told House members that such therapies might offer folks … |
生物通 |
张锋连发两篇Nature子刊文章细述可能超越CRISPR-Cas9的新编辑技术
生物通 2015年，麻省理工学院的张锋研究组发现CRISPR还有一个好朋友——Cpf1。CRISPR-Cpf1也能在crRNA的引导下在人类细胞中剪切目标DNA，被称为是新一代的CRISPR基因组编辑系统。今年张锋研究组在多篇发表于Nature … |
kgw.com |
Blood cancer treatment called ‘revolutionary’ after all study patients responded
kgw.com Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level … |